281 related articles for article (PubMed ID: 27981596)
1. Clinical presentations and outcomes of bile duct loss caused by drugs and herbal and dietary supplements.
Bonkovsky HL; Kleiner DE; Gu J; Odin JA; Russo MW; Navarro VM; Fontana RJ; Ghabril MS; Barnhart H; Hoofnagle JH;
Hepatology; 2017 Apr; 65(4):1267-1277. PubMed ID: 27981596
[TBL] [Abstract][Full Text] [Related]
2. Meropenem-induced vanishing bile duct syndrome.
Schumaker AL; Okulicz JF
Pharmacotherapy; 2010 Sep; 30(9):953. PubMed ID: 20812433
[TBL] [Abstract][Full Text] [Related]
3. Lamotrigine-induced vanishing bile duct syndrome in a child.
Bhayana H; Appasani S; Thapa BR; Das A; Singh K
J Pediatr Gastroenterol Nutr; 2012 Dec; 55(6):e147-8. PubMed ID: 22008955
[No Abstract] [Full Text] [Related]
4. Hydroxycut-related Vanishing Bile Duct Syndrome.
Adike A; Smith ML; Chervenak A; Vargas HE
Clin Gastroenterol Hepatol; 2017 Jan; 15(1):142-144. PubMed ID: 27151488
[No Abstract] [Full Text] [Related]
5. Frequency and pathological characteristics of drug-induced liver injury in a tertiary medical center.
Ettel M; Gonzalez GA; Gera S; Eze O; Sigal S; Park JS; Xu R
Hum Pathol; 2017 Oct; 68():92-98. PubMed ID: 28873351
[TBL] [Abstract][Full Text] [Related]
6. A Case of Vanishing Bile Duct Syndrome after Drug-Induced Liver Injury Caused by Pelubiprofen.
Bak H; Kim H; Lee S; Lee Y; Bang SM; Lee YS
Yonsei Med J; 2020 Dec; 61(12):1060-1063. PubMed ID: 33251781
[TBL] [Abstract][Full Text] [Related]
7. Severe and protracted cholestasis in 44 young men taking bodybuilding supplements: assessment of genetic, clinical and chemical risk factors.
Stolz A; Navarro V; Hayashi PH; Fontana RJ; Barnhart HX; Gu J; Chalasani NP; Vega MM; Bonkovsky HL; Seeff LB; Serrano J; Avula B; Khan IA; Cirulli ET; Kleiner DE; Hoofnagle JH;
Aliment Pharmacol Ther; 2019 May; 49(9):1195-1204. PubMed ID: 30934130
[TBL] [Abstract][Full Text] [Related]
8. Vanishing bile duct syndrome in Hodgkin's lymphoma: A case report and literature review.
Bakhit M; McCarty TR; Park S; Njei B; Cho M; Karagozian R; Liapakis A
World J Gastroenterol; 2017 Jan; 23(2):366-372. PubMed ID: 28127210
[TBL] [Abstract][Full Text] [Related]
9. Cloxacillin-induced acute vanishing bile duct syndrome: A case study and literature review.
Faragalla K; Lau H; Wang HL; Liu J
Br J Clin Pharmacol; 2022 Oct; 88(10):4633-4638. PubMed ID: 35730139
[TBL] [Abstract][Full Text] [Related]
10. Vanishing bile duct syndrome related to DILI and Hodgkin lymphoma overlap: A rare and severe case.
Greca RD; Cunha-Silva M; Costa LBE; Costa JGF; Mazo DFC; Sevá-Pereira T; Nascimento MMC; Pereira IE; Oliveira FC; Faria GAS; Neto FLP; Almeida JRS
Ann Hepatol; 2020; 19(1):107-112. PubMed ID: 31537508
[TBL] [Abstract][Full Text] [Related]
11. [Clinicopathologic features of drug-induced vanishing bile duct syndrome].
Ye LH; Wang CK; Zhang HC; Liu ZQ; Zheng HW
Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):317-320. PubMed ID: 28494557
[TBL] [Abstract][Full Text] [Related]
12. Herbal and Dietary Supplement-Induced Liver Injuries in the Spanish DILI Registry.
Medina-Caliz I; Garcia-Cortes M; Gonzalez-Jimenez A; Cabello MR; Robles-Diaz M; Sanabria-Cabrera J; Sanjuan-Jimenez R; Ortega-Alonso A; García-Muñoz B; Moreno I; Jimenez-Perez M; Fernandez MC; Ginés P; Prieto M; Conde I; Hallal H; Soriano G; Roman E; Castiella A; Blanco-Reina E; Montes MR; Quiros-Cano M; Martin-Reyes F; Lucena MI; Andrade RJ;
Clin Gastroenterol Hepatol; 2018 Sep; 16(9):1495-1502. PubMed ID: 29307848
[TBL] [Abstract][Full Text] [Related]
13. Vanishing bile duct syndrome: a possible mechanism for intrahepatic cholestasis in Hodgkin's lymphoma.
Hubscher SG; Lumley MA; Elias E
Hepatology; 1993 Jan; 17(1):70-7. PubMed ID: 7678577
[TBL] [Abstract][Full Text] [Related]
14. Acute vanishing bile duct syndrome after therapy with cephalosporin, metronidazole, and clotrimazole: A case report.
Zhao Z; Bao L; Yu X; Zhu C; Xu J; Wang Y; Yin M; Li Y; Li W
Medicine (Baltimore); 2017 Sep; 96(36):e8009. PubMed ID: 28885366
[TBL] [Abstract][Full Text] [Related]
15. Drug-induced bile duct injury.
Visentin M; Lenggenhager D; Gai Z; Kullak-Ublick GA
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1498-1506. PubMed ID: 28882625
[TBL] [Abstract][Full Text] [Related]
16. Drug-induced Bile Duct Injury - A Short Review.
Dobreva I; Karagyozov P
Curr Drug Metab; 2020; 21(4):256-259. PubMed ID: 32310045
[TBL] [Abstract][Full Text] [Related]
17. Improvement of vanishing bile duct syndrome with hyperlipidemia.
Yamauchi R; Takata K; Fukunaga A; Tanaka T; Yokoyama K; Shakado S; Nabeshima K; Yoshimitsu K; Hirai F
Clin J Gastroenterol; 2022 Aug; 15(4):784-790. PubMed ID: 35802301
[TBL] [Abstract][Full Text] [Related]
18. Vanishing bile duct syndrome with hyperlipidemia after ibuprofen therapy in an adult patient: a case report.
Xie W; Wang Q; Gao Y; Pan CQ
BMC Gastroenterol; 2018 Sep; 18(1):142. PubMed ID: 30268094
[TBL] [Abstract][Full Text] [Related]
19. Cholestatic syndrome with bile duct damage and loss in renal transplant recipients with HCV infection.
Delladetsima JK; Makris F; Psichogiou M; Kostakis A; Hatzakis A; Boletis JN
Liver; 2001 Apr; 21(2):81-8. PubMed ID: 11318976
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of idiosyncratic drug-induced liver injury in children: results from the DILIN prospective study.
Molleston JP; Fontana RJ; Lopez MJ; Kleiner DE; Gu J; Chalasani N;
J Pediatr Gastroenterol Nutr; 2011 Aug; 53(2):182-9. PubMed ID: 21788760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
